argenX SE Files Form 6-K for December 2024
Ticker: ARGX · Form: 6-K · Filed: Dec 27, 2024 · CIK: 1697862
Sentiment: neutral
Topics: disclosure, sec-filing, foreign-private-issuer
TL;DR
argenx SE filed a 6-K on Dec 27, 2024, providing updates for the month.
AI Summary
On December 27, 2024, argenx SE announced the issuance of a press release. This filing is a Form 6-K report of a foreign private issuer, indicating it is providing information to the SEC for the month of December 2024. The company is incorporated in Belgium and its principal executive offices are located in Amsterdam, the Netherlands.
Why It Matters
This filing serves as an update for investors and the market regarding argenx SE's activities and disclosures as a foreign private issuer. It ensures transparency and compliance with SEC regulations.
Risk Assessment
Risk Level: low — This filing is a routine disclosure report (Form 6-K) and does not contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- argenx SE (company) — Registrant
- December 2024 (date) — Reporting period
- 20241227 (date) — Filing date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of December 2024.
When was this Form 6-K filed?
This Form 6-K was filed on December 27, 2024.
Where are argenx SE's principal executive offices located?
argenx SE's principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
Does argenx SE file annual reports under Form 20-F or Form 40-F?
argenx SE indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 295 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2024-12-27 06:05:23
Filing Documents
- tm2432108d1_6k.htm (6-K) — 11KB
- tm2432108d1_ex99-1.htm (EX-99.1) — 23KB
- tm2432108d1_ex99-1img001.jpg (GRAPHIC) — 2KB
- 0001104659-24-131828.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: December 27, 2024 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel